Aliases & Classifications for Cavernous Malformation

About this section

Aliases & Descriptions for Cavernous Malformation:

Name: Cavernous Malformation 46


Summaries for Cavernous Malformation

About this section
NINDS:46 A cerebral cavernous malformation (CCM) is a collection of small blood vessels (capillaries) in the central nervous system (CNS) that is enlarged and irregular in structure.

MalaCards based summary: Cavernous Malformation is related to cerebral cavernous malformations-1 and cerebral cavernous malformations-2. An important gene associated with Cavernous Malformation is CCM2 (Cerebral Cavernous Malformation 2). Affiliated tissues include endothelial, brain and spinal cord, and related mouse phenotypes are normal and embryogenesis.

Related Diseases for Cavernous Malformation

About this section

Diseases related to Cavernous Malformation via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 102)
idRelated DiseaseScoreTop Affiliating Genes
1cerebral cavernous malformations-130.9CCM2, KRIT1, PDCD10, PTEN
2cerebral cavernous malformations-230.1CCM2, CCM2L, KRIT1, PDCD10
3klippel-trenaunay-weber syndrome29.8CCM2, KRIT1, PDCD10
4venous malformations, multiple cutaneous and mucosal29.7CCM2, KRIT1, PDCD10, PTEN
5cerebritis11.2
6cerebral cavernous malformations 310.7
7cerebral cavernous malformation, familial10.5
8cavernous hemangioma10.5
9congenital vascular cavernous malformations10.5
10endotheliitis10.5
11hemangioma10.4
12familial cerebral cavernous malformation 110.4
13familial cerebral cavernous malformation 210.4
14familial hemangioma10.4
15arteriovenous malformation10.3
16siderosis10.3
17vascular malformation10.3
18familial cerebral cavernous malformation 310.3
19greenberg skeletal dysplasia10.2
20cerebral hemorrhage10.2
21trigeminal neuralgia10.2
22central nervous system hematologic cancer10.2
23central nervous system hemangioma10.2
24cerebral angioma10.2
25brain angioma10.2
26brain cancer10.2
27capillary hemangioma10.2
28central nervous system cancer10.2
29cerebrum cancer10.2
30cervicitis10.2
31congenital nervous system abnormality10.2
32nervous system cancer10.2
33vascular cancer10.2
34vascular disease10.2
35vascular hemostatic disease10.2
36factor v leiden thrombophilia10.2
37familial cerebral cavernous malformation 410.2
38headache10.2
39nevus cavernosus10.2
40vascular erectile tumor10.2
41superficial siderosis10.2
42stroke, ischemic10.2
43trigonitis10.2
44neuronitis10.2
45astrocytoma10.2
46nervous system disease10.2
47retinitis10.2
48neurologic diseases10.2
49cluster headache10.2
50seizure disorder10.2

Graphical network of the top 20 diseases related to Cavernous Malformation:



Diseases related to cavernous malformation

Symptoms for Cavernous Malformation

About this section

Drugs & Therapeutics for Cavernous Malformation

About this section

Drugs for Cavernous Malformation (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
AtorvastatinapprovedPhase 1, Phase 2690134523-00-560823
Synonyms:
(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid
(3R,5R)-7-[3-(anilinocarbonyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid
(R-(R*,R*))-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid
(betaR,deltaR)-2-(p-Fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid
134523-00-5
134523-03-8
7-[2-(4-FLUORO-PHENYL)-5-ISOPROPYL-3-PHENYL-4-PHENYLCARBAMOYL-PYRROL-1-YL]- 3,5-DIHYDROXY-HEPTANOIC ACID
AC-15611
AC1L1TZT
AC1Q1OZQ
AKOS000281127
Atogal
Atorlip
Atorpic
Atorvastatin
Atorvastatin (INN)
Atorvastatin Calcium
Atorvastatin [INN:BAN]
Atorvastatin acid
Atorvastatin calcium
BIDD:GT0336
C06834
C33H35FN2O5
CCRIS 7159
CHEBI:39548
CHEMBL1487
CI 981
CID60823
Cardyl
D07474
DB01076
Faboxim
 
HSDB 7039
Hipolixan
LS-136975
Lipitor
Lipitor (TN)
Lipitor(TM)
Lipotropic
Lipovastatinklonal
Liprimar
Lowden
MolPort-000-883-773
NCGC00159458-02
Normalip
Sincol
Sortis
Sortis (TN)
Sotis
Torvacard
Torvast
Totalip
Tozalip
Tulip
UNII-A0JWA85V8F
Vastina
Xanator
Xarator
Xavator
Zurinel
atorvastatin
atorvastatina
atorvastatine
atorvastatinium
atrovastin
nchembio.301-comp8
2
Doxycyclineapproved, investigationalPhase 1204564-25-054671203, 5281011
Synonyms:
(2E,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4AR,5S,5ar,6R,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
(4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
10597-92-9
17086-28-1 (mono-hydrate)
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS)
24390-14-5
41411-66-9 (6-epimer, mono-hydrochloride)
5-Hydroxy-alpha-6-deoxytetracycline
564-25-0
6-Deoxyoxytetracycline
6-Deoxytetracycline
6-alpha-Deoxy-5-oxytetracycline
6-alpha-deoxy-5-oxytetracycline
69935-17-7 (mono-hydrochloride, di-hydrate)
6alpha-Deoxy-5-oxytetracycline
6╬▒-deoxy-5-oxytetracycline
7164-70-7
7264-10-0
94088-85-4 (calcium salt (1:2))
AB08 (*Fosfatex)
AC1NQXW7
AC1NS4CW
AC1NUYS8
AC1O8PYM
Adoxa
Alodox
Alti-Doxycycline
Apo-Doxy
Atridox
Azudoxat
BCBcMAP01_000024
BIDD:GT0146
BMY-28689
BPBio1_000951
BSPBio_000863
BSPBio_001936
BU-3839T
C06973
CHEBI:50845
CHEMBL1433
CID5281011
CID5353597
CID5463943
CID6713981
CPD001550033
D07876
DB00254
DMSC (*Fosfatex)
DOXCYCLINE ANHYDROUS
DOXY
DOXYCYCLINE CALCIUM
DOXYCYCLINE MONOHYDRATE
Deoxymykoin
DivK1c_000345
Doryx
Dossiciclina
Dossiciclina [DCIT]
Doxcycline anhydrous
Doxiciclina
Doxiciclina [INN-Spanish]
Doxiciclina [Italian]
Doxitard
Doxivetin
Doxy 100
Doxy-Caps
Doxy-Puren
Doxy-Tabs
Doxycen
Doxychel
Doxychel (TN)
Doxycin
Doxycyclin
Doxycycline
Doxycycline (200mg/day) or Placebo
Doxycycline (INN)
 
Doxycycline (TN)
Doxycycline (anhydrous)
Doxycycline (internal use)
Doxycycline Hyclate
Doxycycline Monohydrate
Doxycycline anhydrous
Doxycycline hyclate
Doxycycline hydrochloride
Doxycycline-Chinoin
Doxycyclinum
Doxycyclinum [INN-Latin]
Doxysol
Doxytec
Doxytetracycline
EINECS 209-271-1
GS-3065 (*monohydrate)
HMS2090E06
HSDB 3071
Hydramycin
IDI1_000345
Investin
Jenacyclin
KBio1_000345
KBio2_001287
KBio2_003855
KBio2_006423
KBio3_001156
KBioGR_001133
KBioSS_001287
LS-187766
LS-93868
Liviatin
Lopac0_000405
MolPort-002-507-423
Monodox
Monodox (*monohydrate)
Morgidox
NCGC00161602-01
NCGC00161602-03
NCGC00161602-04
NCGC00167961-01
NCGC00179395-01
NINDS_000345
NSC633557
Novo-Doxylin
Nu-Doxycycline
Ocudox
Oracea
Prestwick0_000852
Prestwick1_000852
Prestwick2_000852
Prestwick3_000852
Ronaxan
SAM002589932
SMP1_000107
SPBio_000246
SPBio_002784
STOCK1N-34341
Spanor
Spectrum2_000143
Spectrum3_000408
Spectrum4_000527
Spectrum5_000947
Spectrum_000807
Supracyclin
UNII-334895S862
UPCMLD-DP021
UPCMLD-DP021:001
Vibra-tabs
Vibramycin
Vibramycin (*monohydrate)
Vibramycin Monohydrate
Vibramycin Novum
Vibramycine
Vibravenos
Vivox (*Hyclate)
alpha-6-Deoxy-5-hydroxytetracycline
alpha-6-Deoxyoxytetracycline
alpha-Doxycycline
doxycycline
3
SimvastatinapprovedPhase 048279902-63-954454
Synonyms:
(+)-Simvastatin
(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate
2,2-Dimethylbutanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester
2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one
2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one
79902-63-9
AC-1530
AC1L1H1F
AKOS005111006
ARONIS24119
BCBcMAP01_000007
BIDD:GT0769
BPBio1_001001
BRD-K22134346-001-05-8
BRN 4768037
BSPBio_000909
BSPBio_002337
Bio-0672
Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,*aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester
Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester
Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester
C25H38O5
CCRIS 7558
CHEBI:9150
CHEMBL1064
CID54454
CPD000718785
Cholestat
Coledis
Colemin
Corolin
D00434
D019821
DRG-0320
Denan
DivK1c_006991
Eucor
HMS1570N11
HMS1922H13
HMS2089D12
HMS2093E06
HSDB 7208
InChI=1/C25H38O5/c1-6-25(4,5)24(28)30-21-12-15(2)11-17-8-7-16(3)20(23(17)21)10-9-19-13-18(26)14-22(27)29-19/h7-8,11,15-16,18-21,23,26H,6,9-10,12-14H2,1-5H3/t15-,16-,18+,19+,20-,21-,23-/m0/s1
KBio1_001935
KBio2_002197
KBio2_004765
KBio2_007333
KBio3_001557
KBioGR_001244
KBioSS_002197
KS-1113
Kolestevan
L 644128-000U
LS-46264
Labistatin
Lipex
Lipinorm
Liponorm
Lipovas
Lodales
MK 0733
MK 733
MK-0733
MK-733
MK733
MLS001304029
MLS001333077
MLS001333078
 
MLS002154038
Medipo
Modutrol
MolPort-002-507-345
MolPort-002-885-862
NCGC00017324-01
NCGC00017324-02
NCGC00017324-03
Nivelipol
Nor-Vastina
Pantok
Pepstatin
Prestwick0_000865
Prestwick1_000865
Prestwick2_000865
Prestwick3_000865
Prestwick_171
Rechol
Rendapid
S1792_Selleck
S6196_SIGMA
SAM002589969
SMR000718785
SPBio_001881
SPBio_002830
SPECTRUM1504236
STK801938
Simcor
Simovil
Simvast CR
Simvastatin
Simvastatin & Primycin
Simvastatin (JAN/USP/INN)
Simvastatin [USAN:INN:BAN]
Simvastatin [Usan:Ban:Inn]
Simvastatin lactone
Simvastatin, Compactin
Simvastatina
Simvastatina [Spanish]
Simvastatine
Simvastatine [French]
Simvastatinum
Simvastatinum [Latin]
Simvotin
Sinvacor
Sinvascor
Sivastin
SpecPlus_000895
Spectrum2_001671
Spectrum3_000669
Spectrum4_000632
Spectrum5_001428
Spectrum_001717
Statin
Synvinolin
TNP00259
UNII-AGG2FN16EV
Valemia
Vasotenal
Velostatin
Vytorin
ZINC03780893
Zocor
Zocor (TN)
Zocor, Simlup, Simcard, Simvacor, Simvoget, Zorced, Simvastatin
Zocord
[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate
butanoic acid, 2,2-dimethyl-,1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)-ethyl]-1-naphthalenyl ester, [1S-[1 alpha,3 alpha,7 beta,8 beta(2S*,4S*),-8a beta
nchembio790-comp16
simvastatin
4AstragalusNutraceutical43

Interventional clinical trials:

idNameStatusNCT IDPhase
1Intracavernous Bone Marrow Stem-cell Injection for Post Prostatectomy Erectile DysfunctionRecruitingNCT01089387Phase 1, Phase 2
2Atorvastatin Therapy in Cerebral Cavernous Malformation: A Proof of Concept Phase I/II TrialNot yet recruitingNCT02603328Phase 1, Phase 2
3Influence of MMP on Brain AVM HemorrhageCompletedNCT00783523Phase 1
4Modifiers of Disease Severity in Cerebral Cavernous MalformationsRecruitingNCT01764529
5Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of StatinsRecruitingNCT01764451Phase 0
6Genetic Disease Gene IdentificationEnrolling by invitationNCT00916903

Search NIH Clinical Center for Cavernous Malformation

Genetic Tests for Cavernous Malformation

About this section

Anatomical Context for Cavernous Malformation

About this section

MalaCards organs/tissues related to Cavernous Malformation:

33
Endothelial, Brain, Spinal cord, Testes, Heart, Pineal, Thalamus

Animal Models for Cavernous Malformation or affiliated genes

About this section

MGI Mouse Phenotypes related to Cavernous Malformation:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00028738.6CCM2, CCM2L, ITGB1BP1, PDCD10, PTEN
2MP:00053808.4CCM2, GLI3, KRIT1, PDCD10, PTEN
3MP:00053828.2CCM2, GLI3, ITGB1BP1, KRIT1, PDCD10, PTEN
4MP:00053917.9CCM2, GLI3, ITGB1BP1, KRIT1, PDCD10, PTEN
5MP:00053857.9CCM2, CCM2L, GLI3, KRIT1, PDCD10, PTEN
6MP:00107687.2CCM2, CCM2L, GLI3, ITGB1BP1, KRIT1, PDCD10

Publications for Cavernous Malformation

About this section

Articles related to Cavernous Malformation:

(show top 50)    (show all 373)
idTitleAuthorsYear
1
Extradural spinal cavernous malformation presenting with radiculopathy. (26386177)
2015
2
Cavernous malformation of the optic chiasm: An uncommon location. (25949848)
2015
3
PDCD10 (CCM3) regulates brain endothelial barrier integrity in cerebral cavernous malformation type 3: role of CCM3-ERK1/2-cortactin cross-talk. (26385474)
2015
4
Cerebral cavernous malformations arise independent of the heart of glass receptor. (24643410)
2014
5
Brainstem melanomas presenting as a cavernous malformation. (24856047)
2014
6
Cerebral cavernous malformations and unilateral moyamoya in a patient with a new mutation in the KRIT-1 /CCM1 gene. (25413039)
2014
7
A call for rigorous study of statins in resolution of cerebral cavernous malformation pathology. (24803598)
2014
8
Case Report: Glioblastoma Multiforme Complicating Familial Cavernous Malformations. (23942770)
2013
9
Mapping affected sites of cavernous malformation in the posterior cranial fossa. (23981232)
2013
10
Cavernous malformations of the brain after treatment for acute lymphocytic leukemia: presentation and long-term follow-up. (23215773)
2013
11
Pitfalls of conservative treatments of multiple probable cerebral cavernous malformations (CCMs): clinicopathological features of CCMs coexisting with vasculogenic mimicry in an anaplastic oligodendroglioma. (24337536)
2013
12
Third ventricular cavernous malformation: an unusual lesion. (23952135)
2013
13
Brainstem cavernous malformation. (23761601)
2013
14
Prediction of outcomes for brainstem cavernous malformation. (23962756)
2013
15
Is cerebral cavernous malformation a pre-glioma lesion? (23253728)
2012
16
Familial cerebral cavernous malformation. (22773461)
2012
17
Massive intracerebral hemorrhage caused by a cavernous malformation. (22396841)
2012
18
Multiple spinal cavernous malformations in Klippel-Trenaunay-Weber syndrome. (23161195)
2012
19
Treatment of pediatric patients with cerebral cavernous malformation. (22209396)
2012
20
Crystallization and preliminary X-ray analysis of the C-terminal domain of CCM2, part of a novel adaptor protein involved in cerebral cavernous malformations. (22684070)
2012
21
A novel CCM1 gene mutation causes cerebral cavernous malformation in a Chinese family. (20884211)
2011
22
Loss of cerebral cavernous malformation 3 (Ccm3) in neuroglia leads to CCM and vascular pathology. (21321212)
2011
23
Cavernous malformation of the trochlear nerve: case report and review of the literature on cranial nerve cavernomas. (21471828)
2011
24
Familial versus sporadic cavernous malformations: differences in developmental venous anomaly association and lesion phenotype. (19833796)
2010
25
Intravenous thrombolysis in a patient with known cavernous malformation: a first case report. (20006229)
2010
26
Angiotensin-converting enzyme insertion/deletion gene polymorphism in patients with familial multiple cerebral cavernous malformations. (20488708)
2010
27
Intraventricular cavernous malformation with superficial siderosis. (20457968)
2010
28
Molecular screening test in familial forms of cerebral cavernous malformation: the impact of the Multiplex Ligation-dependent Probe Amplification approach. (19199464)
2009
29
Phosphatase and tensin homolog in cerebral cavernous malformation: a potential role in pathological angiogenesis. (19061355)
2009
30
ZPLD1 gene is disrupted in a patient with balanced translocation that exhibits cerebral cavernous malformations. (18632209)
2008
31
Spinal root arteriovenous malformations and same-segment cord cavernous malformation in familial cerebral cavernous malformation. Case report. (18928219)
2008
32
Novel human pathological mutations. Gene symbol: KRIT1. Disease: cerebral cavernous malformation. (18380023)
2007
33
Novel human pathological mutations. Gene symbol: KRIT1. Disease: cerebral cavernous malformation. (18383597)
2007
34
Spinal intradural-intramedullary cavernous malformation. Case report and literature review. (16357499)
2006
35
Thoracic intramedullary cavernous malformation with posttraumatic hematomyelia: case report and literature review. (17904054)
2006
36
Cavernous malformation of the internal auditory canal. (16572279)
2006
37
Cavernous malformation of the trigeminal nerve. (16565783)
2006
38
A novel deletion mutation in CCM1 gene (krit1) is detected in a Chinese family with cerebral cavernous malformations. (16529293)
2006
39
Expression of integrins in cerebral arteriovenous and cavernous malformations. (16385340)
2006
40
Cerebral cavernous malformations]. (16100539)
2005
41
Thrombus and encapsulated hematoma in cerebral cavernous malformations. (15759126)
2005
42
Novel CCM1 mutation in a patient with paraparesis and thoracic cord cavernous malformation. (16186553)
2005
43
A novel gene mutation (1292 deletion) in a Chinese family with cerebral cavernous malformations. (15854263)
2005
44
Suprasellar cavernous malformation presenting with extensive subarachnoid hemorrhage. (11338416)
2001
45
Chiasmal cavernous malformation. A rare cause of acute visual loss. (11327292)
2000
46
Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). (10545614)
1999
47
De novo formation of a central nervous system cavernous malformation: implications for predicting risk of hemorrhage. Case report and review of the literature. (9322853)
1997
48
Recurrent chiasmal apoplexy due to cavernous malformation. (8797165)
1996
49
Stereotactically guided cavernous malformation surgery. (8811657)
1996
50
Mapping a gene causing cerebral cavernous malformation to 7q11.2-q21. (7604043)
1995

Variations for Cavernous Malformation

About this section

Expression for genes affiliated with Cavernous Malformation

About this section
Search GEO for disease gene expression data for Cavernous Malformation.

Pathways for genes affiliated with Cavernous Malformation

About this section

GO Terms for genes affiliated with Cavernous Malformation

About this section

Biological processes related to Cavernous Malformation according to GeneCards Suite gene sharing:

(show all 9)
idNameGO IDScoreTop Affiliating Genes
1negative regulation of cell migration involved in sprouting angiogenesisGO:009005110.2ITGB1BP1, PDCD10
2positive regulation of Notch signaling pathwayGO:004574710.1ITGB1BP1, PDCD10
3negative regulation of protein bindingGO:003209110.0CCM2L, ITGB1BP1
4negative regulation of focal adhesion assemblyGO:005189510.0ITGB1BP1, PTEN
5integrin-mediated signaling pathwayGO:00072299.7CCM2, ITGB1BP1
6inner ear developmentGO:00488399.6CCM2, GLI3
7angiogenesisGO:00015259.5KRIT1, PDCD10, PTEN
8negative regulation of cell proliferationGO:00082859.1GLI3, ITGB1BP1, PTEN
9heart developmentGO:00075078.8CCM2, GLI3, PTEN

Molecular functions related to Cavernous Malformation according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1protein kinase bindingGO:00199019.1ITGB1BP1, PDCD10, PTEN

Sources for Cavernous Malformation

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet